. . . . . . . "78439-06-2"@en . "Ceftazidime"@en . . "Ronald C. Browning, Melvin G. Pleiss, Jr., \"Crystallization process for ceftazidime derivative.\" U.S. Patent US4659813, issued May, 1982."@en . . . "Ceftazidima"@en . . . "Semisynthetic, broad-spectrum antibacterial derived from cephaloridine and used especially for Pseudomonas and other gram-negative infections in debilitated patients. [PubChem]"@en . "< 10%"@en . . . . . . "Ceftazidim"@en . . . . "Ceftazidime"@en . . "approved"@en . . . . . . . . . . "* 115 mL/min"@en . . . . . . . "Ceftazidimum"@en . . "The absorption of ceftazidime is directly proportional to the size of the dose."@en . . . . "Ceftazidime anhydrous"@en . " "@en . . "Enteric bacteria and other eubacteria"@en . . . . . . . . . . . . . . . . "The elimination of ceftazidime by the kidneys resulted in high therapeutic concentrations in the urine."@en . . . . . . . . . "(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate"@en . . . "Ceftazidime overdosage has occurred in patients with renal failure. Reactions have included seizure activity, encephalopathy, asterixis, neuromuscular excitability, and coma."@en . . . . "Half-life, following IV administration, is approximately 1.9-hours. Since ceftazidime is eliminated almost solely by the kidneys, its serum half-life is significantly prolonged in patients with impaired renal function."@en . . . . . . "The bactericidal activity of ceftazidime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs)."@en . . . . . . "For the treatment of patients with infections caused by susceptible strains of organisms in the following diseases: lower respiratory tract infections,skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra abdominal infections (including peritonitis), and central nervous system infections (including meningitis)."@en . . . . . "CAZ"@en . . . . . " "@en . . . . . . . . . . . . .